Over-the-counter medication · Progestin
levonorgestrel
Also sold as Plan B, Mirena. Iclevia is used to prevent pregnancy in women who are able to have children.
Data updated 2026-05-15
- 197,074
- FDA reportsHeavily reported
- 37
- InteractionsSeveral interactions
- $5.97
- Generic price (NADAC)
What the data shows
levonorgestrel (Plan B) is an over-the-counter Progestin, more reported than roughly 9 in 10 tracked drugs (197,074 FDA reports), with 37 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
levonorgestrel (Plan B) is an over-the-counter Progestin. Iclevia is used to prevent pregnancy in women who are able to have children.
Iclevia is a birth control pill that you take every day to prevent pregnancy. It contains two hormones, levonorgestrel and ethinyl estradiol.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$5.97/unit
Generic Available
Yes (51 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
NADAC price trail: LEVONORGESTREL 1.5 MG TABLET
Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: -12.4% vs prior release.
| Effective | NADAC / unit | vs prior | NDCs |
|---|---|---|---|
| September 18, 2024 | $6.81/EA | - | 1 |
| December 18, 2024 | $5.97/EA | -12.4% | 2 |
What it does
Iclevia is used to prevent pregnancy in women who are able to have children.
Common side effects
Headache, Heavy menstrual bleeding, Nausea
Key warnings
Cigarette smoking increases your risk of serious heart problems from birth control pills.
The sections below are summarized in plain English from levonorgestrel's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Iclevia prevents pregnancy by stopping ovulation (the release of an egg from the ovary). It also changes the lining of the uterus, making it harder for a fertilized egg to implant. This medicine also changes the mucus in the cervix, which makes it difficult for sperm to go into the uterus.
Side Effects (from patient reports)
Based on 197,074 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for levonorgestrel, by number of reports
- Device Expulsion
Device Expulsion
44,866 reports
- Device Dislocation
Device Dislocation
19,863 reports
- Menstruation Irregular 14,989
Menstruation Irregular
14,989 reports
- Vaginal Haemorrhage 14,819
Vaginal Haemorrhage
14,819 reports
- Genital Haemorrhage 10,916
Genital Haemorrhage
10,916 reports
- Abdominal Pain Lower 9,175
Abdominal Pain Lower
9,175 reports
- Abdominal Pain 8,552
Abdominal Pain
8,552 reports
- Nausea 8,441
Nausea
8,441 reports
- Procedural Pain 8,262
Procedural Pain
8,262 reports
- Pain 7,480
Pain
7,480 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for levonorgestrel each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where levonorgestrel sits
levonorgestrel has more FDA adverse-event reports than 94% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is levonorgestrel; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 197,074 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
197,074
Reports Mentioning Death
267
0.1% of reports — not proof of cause
Hospitalization Reports
10,709
Top Indication
Contraception
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | DEVICE EXPULSION | 44,866 |
| 2 | DEVICE DISLOCATION | 19,863 |
| 3 | MENSTRUATION IRREGULAR | 14,989 |
| 4 | VAGINAL HAEMORRHAGE | 14,819 |
| 5 | GENITAL HAEMORRHAGE | 10,916 |
| 6 | ABDOMINAL PAIN LOWER | 9,175 |
| 7 | ABDOMINAL PAIN | 8,552 |
| 8 | NAUSEA | 8,441 |
| 9 | PROCEDURAL PAIN | 8,262 |
| 10 | PAIN | 7,480 |
| 11 | UTERINE PERFORATION | 7,396 |
| 13 | PELVIC PAIN | 6,801 |
| 14 | HEADACHE | 6,407 |
| 15 | PREGNANCY WITH CONTRACEPTIVE DEVICE | 5,890 |
| 16 | MENSTRUATION DELAYED | 5,744 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke more cigarettes. If you are over 35 and smoke, you should not take Iclevia.
Known Drug Interactions
Co-administration of Iclevia and glecaprevir/pibrentasvir is not recommended due to potential for ALT elevations.
Mechanism: Taking these drugs together can cause your liver enzymes to rise, which may be a sign of liver irritation.
Substances increasing the systemic exposure of COCs: Co-administration of atorvastatin or rosuvastatin and certain COCs containing ethinyl estradiol (EE) increase AUC values for EE by approximately 20 to 25%.
Mechanism: Atorvastatin can increase the amount of birth control hormones that stay in your blood by about 20 to 25 percent.
Substances increasing the systemic exposure of COCs: Co-administration of atorvastatin or rosuvastatin and certain COCs containing ethinyl estradiol (EE) increase AUC values for EE by approximately 20 to 25%.
Mechanism: Rosuvastatin can raise the levels of birth control hormones in your blood by changing how your body processes them.
Examples Aprepitant, barbiturates, bosentan, carbamazepine, efavirenz, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, rifabutin, rufinamide, topiramate, products containing St.
Mechanism: Topiramate makes your liver work faster to clear birth control hormones from your system. This can make your birth control less effective and increase the risk of pregnancy.
Concomitant use with ethinyl estradiol-containing COCs may increase systemic exposure of other drugs (e.g., cyclosporine, prednisolone, theophylline, tizanidine, and voriconazole).
Mechanism: Birth control pills can slow down how your body gets rid of tizanidine. This can cause the medicine to build up in your blood and lead to more side effects.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
What should I do if I experience severe abdominal pain?
Can I take Iclevia if I have high blood pressure?
Does Iclevia protect against sexually transmitted infections (STIs)?
What if I have a family history of blood clots?
Can I take Iclevia if I am over 40?
Will I still get my period while taking Iclevia?
What if I have liver problems?
Can I take Iclevia with other medications?
What are the signs of a blood clot?
Is it normal to have irregular bleeding while taking Iclevia?
What are the common side effects of levonorgestrel?
Does levonorgestrel interact with other medications?
What drug class is levonorgestrel?
What pregnancy or breastfeeding source fields are listed for levonorgestrel?
Related Medications in Progestin
Other drugs grouped near levonorgestrel - same-class peers and common alternatives.
abiraterone
Zytiga
Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread.
Compare with levonorgestrel →
anastrozole
Arimidex
Anastrozole is a medicine used to treat breast cancer in women after menopause.
Compare with levonorgestrel →
bazedoxifene/conjugated estrogens
Duavee
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body.
Compare with levonorgestrel →
cabergoline
Dostinex
Cabergoline is a medicine that helps lower the amount of prolactin in your body.
Compare with levonorgestrel →
clomiphene
Clomid, Serophene
Clomiphene citrate is a medicine that helps women ovulate.
Compare with levonorgestrel →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for levonorgestrel: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 197,074.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 0.14%.
- etonogestrel Δ 0.06 pts · 46,939 reports · Progestin (Implant) 0.20%death share
- adapalene Δ 0.12 pts · 178,147 reports · Retinoid (Topical) 0.02%death share
- crisaborole Δ 0.12 pts · 9,400 reports · PDE4 Inhibitor (Topical) 0.26%death share
- dupilumab Δ 0.29 pts · 411,692 reports · Anti-IL-4/IL-13 Monoclonal Antibody 0.43%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen, which OTC pain reliever to use
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
What the FDA Data Shows for levonorgestrel
The FDA label for levonorgestrel (sold under brand names such as Plan B, Mirena) classifies it as an over-the-counter product in the Progestin class. Iclevia is used to prevent pregnancy in women who are able to have children. Official labeling lists 9 commonly reported side effects, including Headache, Heavy menstrual bleeding, Nausea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 197,074 voluntary reports. The database also lists 37 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $5.97.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: July 2, 2024
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages